You just read:

Jazz Pharmaceuticals And Celator Pharmaceuticals Announce Agreement For Jazz Pharmaceuticals To Acquire Celator For $30.25 Per Share

News provided by

Jazz Pharmaceuticals plc

31 May, 2016, 08:30 BST